Deakin, named after Australia’s second Prime Minister, is a young contemporary university with a reputation for being innovative, nimble and friendly. We aspire every day to combine excellent research and outstanding teaching with a strong focus on the communities we serve. Deakin is ranked in the top 2 per cent of the world’s universities in each of the major rankings and ranking 211 in the Academic Ranking of World Universities (ARWU). Deakin researchers are making a difference through world-class research and innovation. Deakin has a strong sense of community and serves as an economic, social and cultural catalyst enriching each of the communities it serves.
Elsevier is a global information analytics business that helps institutions and professionals advance healthcare, open science and improve performance for the benefit of humanity. At Elsevier, we publish a wide variety of scientific research journals and books, including an excellent choice of Parasitology titles, that offer a range of ways you can make your work open access.
With more than 30 years of experience, Integrated DNA Technologies (IDT) is a world-leading developer and manufacturer of products for research across the spectrum of the life sciences disciplines. From our early years as an oligonucleotide provider, we have evolved to offer full solutions over a range of applications and technologies. What hasn’t changed is our world-class customer support, or our unique, non-array–based manufacturing and quality control methods, which allow us to deliver nucleic acid reagents that consistently outperform competing products. In addition to our core oligo business, today we supply
performance-focused NGS solutions, from library preparation to target capture, that increase discovery potential. We also offer CRISPR reagents and kits that include guide RNAs, proprietary nucleases, and enhancers for homology directed repair.
QIMR Berghofer Medical Research Institute is a world-leading translational research institute where research develops from the laboratory bench through to the patient’s bedside and is one of Australia’s largest and most successful institutes.
For over 70 years, QIMR Berghofer has led advances in the understanding, prevention, control, diagnosis and treatment of disease.
QIMR Berghofer focuses on cancer, infectious diseases, chronic disorders and mental health, and has developed impressive capability in genomics across these programs.